TruCCOMS is a continuous cardiac output monitoring system that gives clinicians real-time, second-by-second cardiac output measurements at the bedside. The beat-by-beat measurements are not averaged so clinicians can be sure they are making clinical decisions based on real-time events, not historical data. The system works on a principle of heat transfer and thus eliminates the requirement for intermittent thermodilution measurements to be made, saving time and eliminating the fluid boluses required with thermodilution.

PiCCO plus is the only hemodynamic monitor showing a complete picture of the hemodynamic situation (flow, preload, afterload, contractility, volume responsiveness and lung water). The measurement of extravascular lung water is a unique feature and allows early recognition and follow up of pulmonary edema. There are no PAC-associated complications — the risk profile is minimized.
The system is a comprehensive hemodynamic management tool providing information regarding cardiac preload volumes, cardiac function as well as bedside measurement of pulmonary edema.

The mCare 300 Vital Signs Monitor can be used to assess patient essential vital signs quickly. At the touch of a button, clinicians can initiate a stat NIBP reading, record desired parameters (with the optional two-channel integrated recorder), enlarge numeric values for greater visibility or silence alarms. Single-level menus assure instant access to the desired parameter.
The monitor includes basic arrhythmia monitoring with alarms for high and low heart rate, ventricular fibrillation and asystole. It can be used in adult, pediatric and neonatal settings.

USCOM is a CW doppler-based hemodynamic monitor that provides real-time information from either the right or left side of the heart. The technique is entirely noninvasive, with no patient risk and no proprietary disposables. USCOM has been validated against bench flow models, flow-probes, echo, PAC and artificial hearts in animals, pediatrics and adults.
The system provides information regarding preload, contractility and afterload and has numerous applications in the PICU, ED, MICU, burn and trauma units. On-site training is provided.

GE Healthcare is exhibiting new methods in ventilation monitoring to help enhance critical patient care and to further expand the performance of its Engstrom Carestation ventilator. Developed with Professor Ola Stenqvist, M.D., Ph.D., intensivist and anesthesiologist at Sahlgrenska University Hospital in Gothenburg, Sweden, the breakthrough options of SpiroDynamics and FRC INview (Functional Residual Capacity) are based on validated algorithms and measurements. The Engstrom Carestation ventilator is being showcased Dec.

Cook Medical, the world’s largest privately owned medical device manufacturer, has announced the availability of the Cook EchoTip Echogenic Needle to enhance the needle’s appearance during ultrasound imaging.

A&T Inc. today announced it has signed a three-year optical and data services contract with California Advanced Imaging Medical Associates (CAIMA), a radiology practice serving the leading hospitals in the western San Francisco Bay Area and throughout the United States, in which AT&T will serve as the primary provider of data and networking services.

The medical imaging community was stunned Monday when Congress adjourned for the year before making adjustments to the Deficit Reduction Act of 2005. DRA provisions that cut Medicare reimbursement for outpatient imaging procedures will take effect as mandated on Jan. 1.

Congress failed to act on two bills that would have delayed the DRA's technical component cuts for outpatient imaging services for at least two years, pending a federal study into the impact of the cuts on access to care.

Earlier this year, bird flu panic was in full swing: The French feared for their foie gras, the Swiss locked their chickens indoors, and Americans enlisted prison inmates in Alaska to help spot infected wild birds.

The H5N1 virus — previously confined to Southeast Asia — was striking birds in places as diverse as Germany, Egypt, and Nigeria, and a flu pandemic seemed inevitable.

Then the virus went quiet. Except for a steady stream of human cases in Indonesia, the current flu epicenter, the past year's worries about a catastrophic global outbreak largely disappeared.

Epix Pharmaceuticals Inc. announced that results from a Phase IIa clinical trial of EP-2104R found that the imaging agent was able to detect blood clots not previously seen on MRI and enhanced images previously seen.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now